Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Citius Pharmaceuticals Inc
CTXR
Healthcare
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. It develops and commercializes critical care products with a focus on oncology, anti-infectives in adjunct cancer care, prescription products and stem cell therapy. Its products include LYMPHIR, Mino-Lok, Halo-Lido, NoveCite and Mino-Wrap. LYMPHIR is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of...
patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. Halo-Lido is a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids. Mino-Wrap is a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries. NoveCite is a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CTXR)
New Post
View:
Posts & Comments
Threaded Posts
(37)
•••
BryceCanada
X
Post by
BryceCanada
on Nov 11, 2024 8:03pm
Big news out today for CTXR
https://youtu.be/tU1AzxFwptw?si=cOPKMeHbzN7wkKVX
(37)
•••
BryceCanada
X
Post by
BryceCanada
on Sep 23, 2024 9:07am
New video out on CTXR
https://youtu.be/W4lOTWn3uRY?si=_KnuRrHt8WGledKD
Access North American AND Australian listed and Pre-IPO opportunities – here!
posted Dec 02, 2024 9:00am by
Stockhouse Publishing Ltd.
-
|
For the first time on Stockhouse, Canadian investors can access ASX-listed opportunities through our partnership with HotCopper in Australia, opening doors to high-potential investments at the click of a button. Learn more here… ...read more
(37)
•••
BryceCanada
X
Post by
BryceCanada
on Jul 16, 2024 8:08am
New coverage out on CTXR
https://youtu.be/5rfNA18dGZM?si=JWS4rAcKdq-RrQJh
(268)
•••
whytestocks
X
Post by
whytestocks
on Feb 14, 2024 4:45pm
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 20
Just In: $CTXR Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business UpdateCitius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial
...more
(37)
•••
BryceCanada
X
Post by
BryceCanada
on May 03, 2022 11:29am
new CTXR research report - great read!
https://marketresearchrepository.com/cancer-breakthrough-of-the-decade/?utm_source=mcnalliemoney+&utm_medium=influencer&utm_campaign=ctxrz_us
(37)
•••
BryceCanada
X
Post by
BryceCanada
on May 03, 2022 10:18am
Excellent YT analysis on Citius Pharmaceuticals!
https://youtu.be/hRHnqSPnhdU
(2)
•••
Adwari
X
Comment by
Adwari
on Jun 15, 2021 11:25am
RE:Grab hold!
I like the speed CTXR is rolling at, especially when the overall market is down. Sure $5-$7 in sight.
(27)
•••
Doinitmyway
X
Post by
Doinitmyway
on Jun 15, 2021 10:42am
Grab hold!
SP climbing nicely in anticipation of phase 3 results news and of June. Thinking we will see mid $3 range up to news on successful p3 results above $5 maybe $6. Imo. Long CTXR
(0)
•••
FrugalNorwegian
X
Post by
FrugalNorwegian
on May 12, 2021 12:52pm
New website with deep DD on CTXR 👇
New site with Deep DD on CTXR: Frugalnorwegian.com/ctxr - All information on 1 page - Catalyst countdown timer - Several videos to watch - Provides a high level summary, and goes deep into the
...more
(2)
•••
Adwari
X
Post by
Adwari
on May 04, 2021 5:56pm
$8.00 Target
https://dawsonjames.com/wp-content/uploads/2021/03/CTXR.3.10.21.pdf?inf_contact_key=154f539fd109d5209738a76e572922421b0a3f0fd3ee5d9b43fb34c6613498d7
(27)
•••
Doinitmyway
X
Post by
Doinitmyway
on Apr 30, 2021 4:34pm
Not to late!
Still time to load up. News out in May on phase 3 results. This will be in $3 to $4 range soon IMO. Long CTXR
(27)
•••
Doinitmyway
X
Post by
Doinitmyway
on Apr 27, 2021 9:14am
Lift off!!!
$3.00 + range soon time to load up IMO. Long CTXR
(27)
•••
Doinitmyway
X
Post by
Doinitmyway
on Feb 23, 2021 9:22am
So Quiet???
with all the hype out there in social media land and the volume traded in this stock.......shocked and amazed how quiet this board is. Long CTXR
(24)
•••
Marphine
X
Comment by
Marphine
on Feb 20, 2021 8:11am
RE:this one is
Good to go, now that they are fully cashed up?
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec